TEL-AML1 fusion in childhood acute lymphoblastic leukaemia (ALL): Demographics, clinical features, cytogenetic characteristics and prognosis

TEL-AML1 fusion in childhood acute lymphoblastic leukaemia (ALL): Demographics, clinical features, cytogenetic characteristics and prognosis

Bibliographic Details
Main Authors:	Moorman, A, Richards, S, Martineau, M, Cheung, K, Robinson, H, Broadfield, Z, Barber, K, Lilleyman, J, Kinsey, SE, Eden, O, Vora, A, Mitchell, C, Harrison, C
Format:	Conference item
Published:	2005

Similar Items

Delineation of Risk Factors in Paediatric Acute Lymphoblastic Leukaemia with Favourable Cytogenetics
by: Moorman, A, et al.
Published: (2012)

Three distinct subgroups of hypodiploidy in acute lymphoblastic leukaemia.
by: Harrison, C, et al.
Published: (2004)

Karyotype and prognosis in childhood acute lymphoblastic leukemia (ALL) in the UK medical research council (MRC) ALL97 trial.
by: Moorman, A, et al.
Published: (2003)

Cytogenetic-specific heterogeneity in the kinetics of minimal residual disease (MIRD) clearance in childhood lymphoblastic leukaemia (ALL)
by: Moorman, A, et al.
Published: (2008)

Intraocular relapse of childhood acute lymphoblastic leukaemia.
by: Somervaille, T, et al.
Published: (2003)

Benefit of dexamethasone compared with prednisolone for childhood acute lymphoblastic leukaemia: results of the UK Medical Research Council ALL97 randomized trial.
by: Mitchell, C, et al.
Published: (2005)

Toxicity and efficacy of 6-thioguanine versus 6-mercaptopurine in childhood lymphoblastic leukaemia: a randomised trial.
by: Vora, A, et al.
Published: (2006)

Cytogenetic-specific heterogeneity in the kinetics of minimal residual disease (MRD) clearance in childhood acute lymphoblastic leukaemia (ALL)
by: Moorman, A, et al.
Published: (2007)

Amplification of AML1 in acute lymphoblastic leukemia is associated with a poor outcome.
by: Robinson, H, et al.
Published: (2003)

Prognostic Relevance of Cytogenetics in Childhood Acute Lymphoblastic Leukaemia (ALL): Final Results From MRC ALL97.
by: Moor-Man, A, et al.
Published: (2009)

Late relapsing childhood lymphoblastic leukaemia.
by: Frost, L, et al.
Published: (1997)

Thioguanine compared with mercaptopurine in childhood lymphoblastic leukaemia: Results of the United Kingdom medical research council randomised trial ALL97.
by: Lennard, L, et al.
Published: (2005)

Late relapsing childhood acute lymphoblastic leukaemia.
by: Frost, L, et al.
Published: (1998)

Secondary acute myeloid leukaemia in children treated for acute lymphoblastic leukaemia.
by: Eden, O, et al.
Published: (1998)

Thioguanine-related veno-occlusive disease (VOD) of the liver in children with acute lymphoblastic leukaemia (ALL): Report from United Kingdom Medical Research Council (UK MRC) trial ALL97.
by: Vora, A, et al.
Published: (2002)

Benefit of targeted intensification for NCI high risk childhood lymphoblastic leukaemia: Results of the United Kingdom medical research council trial ALL97 and ALL97/99.
by: Vora, A, et al.
Published: (2006)

Blast cell vacuoles in childhood lymphoblastic leukaemia.
by: Lilleyman, J, et al.
Published: (1988)

Benefit of intensified treatment for all children with acute lymphoblastic leukaemia: results from MRC UKALL XI and MRC ALL97 randomised trials. UK Medical Research Council's Working Party on Childhood Leukaemia.
by: Hann, I, et al.
Published: (2000)

Testicular irradiation in childhood lymphoblastic leukaemia. Medical Research Council Working Party on Leukemia in Childhoods.
by: Eden, O, et al.
Published: (1990)

The Spectrum and Prognostic Relevance of Additional Abnormalities, Involving 12p and 21q, in Children with ETV6-RUNX1 Positive Acute Lymphoblastic Leukaemia (ALL)
by: Moorman, A, et al.
Published: (2008)

Three distinct subgroups of hypodiploidy in acute lymphoblastic leukemia in UK MRC trials.
by: Harrison, C, et al.
Published: (2003)

The thiopurine methyltransferase TPMT *1/*3A genotype is associated with a better treatment outcome in the UK ALL97 trial for childhood acute lymphoblastic leukaemia; TPMT heterozygosity is not associated with secondary cancers
by: Lennard, L, et al.
Published: (2010)

Acute lymphoblastic leukaemia in infancy: experience in MRC UKALL trials. Report from the Medical Research Council Working Party on Childhood Leukaemia.
by: Chessells, J, et al.
Published: (1994)

Treatment of high risk leukaemia - Results of MRC childhood acute lymphoblastic leukaemia study MRC HR-1.
by: Kinsey, S, et al.
Published: (2002)

Gender and treatment outcome in childhood lymphoblastic leukaemia: report from the MRC UKALL trials.
by: Chessells, J, et al.
Published: (1995)

Outcome heterogeneity in childhood high-hyperdiploid acute lymphoblastic leukemia.
by: Moorman, A, et al.
Published: (2003)

Temporal changes in the incidence and pattern of central nervous system relapses in children with acute lymphoblastic leukaemia treated on four consecutive Medical Research Council trials, 1985-2001.
by: Krishnan, S, et al.
Published: (2010)

Variables affecting kinetics of minimal residual disease clearance in children with lymphoblastic leukaemia; Results of the United Kingdom Medical Research Council (UK MRC) protocols ALL97, ALL97/99 and ALL2003.
by: Vora, A, et al.
Published: (2005)

The clinical pharmacology of thioguanine vs. mercaptopurine in ALL97, a randomized trial for the treatment of childhood lymphoblastic leukaemia
by: Lennard, L, et al.
Published: (2008)

Continuing (maintenance) therapy in lymphoblastic leukaemia: lessons from MRC UKALL X. Medical Research Council Working Party in Childhood Leukaemia.
by: Chessells, J, et al.
Published: (1997)

French American British (FAB) morphological classification of childhood lymphoblastic leukaemia and its clinical importance.
by: Lilleyman, J, et al.
Published: (1986)

High hyperdiploidy among adolescents and adults with acute lymphoblastic leukaemia (ALL): Cytogenetic features, clinical characteristics and outcome
by: Chilton, L, et al.
Published: (2014)

High hyperdiploidy among adolescents and adults with acute lymphoblastic leukaemia (ALL): cytogenetic features, clinical characteristics and outcome.
by: Chilton, L, et al.
Published: (2014)

High hyperdiploidy among adolescents and adults with acute lymphoblastic leukaemia (ALL): cytogenetic features, clinical characteristics and outcome
by: Chilton, L, et al.
Published: (2014)

Prognostic effect of chromosomal abnormalities in childhood B-cell precursor acute lymphoblastic leukaemia: results from the UK Medical Research Council ALL97/99 randomised trial.
by: Moorman, A, et al.
Published: (2010)

Cytomorphology of childhood lymphoblastic leukaemia: a prospective study of 2000 patients. United Kingdom Medical Research Council's Working Party on Childhood Leukaemia.
by: Lilleyman, J, et al.
Published: (1992)

Prognostic importance of myelosuppression during maintenance treatment of lymphoblastic leukaemia. Leukaemia in Childhood Working Party of the Medical Research Council.
by: Dolan, G, et al.
Published: (1989)

Clinical features, cytogenetics and outcome in acute lymphoblastic and myeloid leukaemia of infancy: report from the MRC Childhood Leukaemia working party.
by: Chessells, J, et al.
Published: (2002)

Successful treatment without cranial radiotherapy of children receiving intensified chemotherapy for acute lymphoblastic leukaemia: results of the risk-stratified randomized central nervous system treatment trial MRC UKALL XI (ISRC TN 16757172).
by: Hill, F, et al.
Published: (2004)

Treatment of infants with lymphoblastic leukaemia: results of the UK Infant Protocols 1987-1999.
by: Chessells, J, et al.
Published: (2002)